Tech Company Financing Transactions
Cellarity Funding Round
BlackRock, Flagship Pioneering and The Baupost Group joined a $123 million Series B funding round for Cellarity. The funding round closed on 3/1/2021.
Transaction Overview
Company Name
Announced On
3/1/2021
Transaction Type
Venture Equity
Amount
$123,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Technology Sq. 6th Floor
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company's broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fabrice Chouraqui
Chief Marketing Officer
Milind Kamkolkar
Chief Technical Officer
Chad Nusbaum
Co-Founder
Nick Plugis
Vice President
Effie Tozzo
VP - Product Management
Raffi Afeyan
Browse more venture capital transactions:
Prev: 3/1/2021: Lexer venture capital transaction
Next: 3/1/2021: Levitate venture capital transaction
Share this article
About Our VC Transactions Data
We document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs